Biomarin Pharmaceutical Inc (BMRN) — Cash Flow Quality Index
Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Quality Index of 3.76x as of June 2026. Operating cash flow of $168.11 Million exceeds net income of $44.76 Million, indicating high earnings quality where cash backs reported profits. Explore how well can Biomarin Pharmaceutical Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biomarin Pharmaceutical Inc Cash Flow Quality Index (2008–2025)
Historical Cash Flow Quality Index for Biomarin Pharmaceutical Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Biomarin Pharmaceutical Inc operating cash flow efficiency.
Annual Cash Flow Quality Index for Biomarin Pharmaceutical Inc (2008–2025)
Year-by-year earnings quality comparison for Biomarin Pharmaceutical Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.37x | $827.99 Million | $348.90 Million | ▲ +76.8% |
| 2024 | 1.34x | $572.84 Million | $426.86 Million | ▲ +41.3% |
| 2023 | 0.95x | $159.26 Million | $167.65 Million | ▼ -23.5% |
| 2022 | 1.24x | $175.90 Million | $141.56 Million | ▲ +1150.5% |
| 2020 | 0.10x | $85.36 Million | $859.10 Million | ▲ +9.1% |
| 2010 | 0.09x | $18.75 Million | $205.82 Million | ▲ +130.6% |
| 2008 | -0.30x | $-9.18 Million | $30.83 Million | — |